マサチューセッツ・ファイナンシャル・サービセズ・カンパニー Cuts Stake in スギホールディングス (7649) to 5% | Large Shareholding Report

A large shareholding report (EDINET filing) shows that Massachusetts Financial Services Company reduced its stake in Sugi Holdings (7649) to 5%. This sale represents a reduction by a major U.S. asset management group. Sugi Holdings operates the drugstore chain "Sugi Pharmacy" nationwide and ranks as a leading retailer of pharmaceuticals and daily necessities, with this 5% stake representing a significant position in the company's issued shares. Massachusetts Financial Services first disclosed a 6.12% stake on November 19, 2025, and has now lowered it to 5%, marking a phased reduction of over 1 percentage point in just under a year.

Massachusetts Financial Services' Holdings in Sugi Over Time

Massachusetts Financial Services Company reported a 6.12% stake in its initial filing on November 19, 2025, declining to 5% as of August 6, 2026. This 1.12 percentage point decrease occurred over approximately eight months. The estimated proceeds from the sale reached ¥5.75 billion, based on a stock price of ¥2,757 per share. The filing represents a change report documenting ongoing reduction rather than a single liquidation event.

Position Within Sugi Holdings' Shareholder Base

Sugi Shoji dominates Sugi Holdings as a controlling shareholder with 35.65%. Below that level, Orbis Investment Management Limited holds 5.01%, positioning Massachusetts Financial Services at a comparable tier with its 5% holding. Robeco Institutional Asset Management B.V. trails at 1.86%, showing more modest involvement despite being a major global investment group. The structure reveals Sugi Shoji's overwhelming control with foreign investment funds participating at several percentage points each.

Comparison With Massachusetts Financial Services' Other Holdings

Massachusetts Financial Services maintains stakes above 5% in thirteen total securities beyond Sugi Holdings. The largest position is Resonac Holdings (chemicals, 9.39%), followed by Terumo (precision equipment, 6.56%), Kose Holdings (chemicals, 6.09%), Nitori Holdings (retail, 5.41%), and Daiseki (services, 5.23%). Sugi Holdings' drugstore retail segment appears integrated within a diversified portfolio spanning chemicals, precision equipment, and other sectors.

Valuation Metrics and Stock Price Position

Sugi Holdings showed a PER of 11.1x and PBR of 1.72x at the filing date. The 11.1x PER suggests the stock trades at a discount relative to typical Japanese equity valuations, indicating modest earnings-based pricing. The 1.72x PBR reflects continued market valuation above book value. The 3% position within the 52-week range reveals the current stock price sits near annual lows, with most trading occurring at higher levels over the past year.

*Speculation: The U.S. asset management firm's phased sale may reflect shifts in competitive dynamics within the drugstore retail sector or portfolio reallocation priorities.